StockData
Balchem Corp logo

Balchem Corp (BCPC) stock

BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 19/3014% above fair value
$168.73−0.90 (-0.53%)

Close on Nov 18, 2026Market cap $5.36BP/E 31.8Yield 0.57%

Balchem operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Balchem's operating income for the twelve months ending Sep 30, 2026 was $229.57M, up 12.3% year over year. For fiscal 2025 it was $209.33M, up 14.4% from the year before. Over ten years it grew 8.3% a year on average. The highest annual figure on record is $209.33M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$209.33M+14.4%
FY2024Dec 31, 2024$182.91M+14.9%
FY2023Dec 31, 2023$159.19M+9.6%
FY2022Dec 31, 2022$145.19M+13.9%
FY2021Dec 31, 2021$127.50M+14.7%
FY2020Dec 31, 2020$111.15M+8.4%
FY2019Dec 31, 2019$102.55M-4.2%
FY2018Dec 31, 2018$107.10M+10.5%
FY2017Dec 31, 2017$96.90M+6.7%
FY2016Dec 31, 2016$90.84M-3.3%
FY2015Dec 31, 2015$93.96M+14.4%
FY2014Dec 31, 2014$82.14M+25.2%
FY2013Dec 31, 2013$65.60M+9.7%
FY2012Dec 31, 2012$59.78M+6.3%
FY2011Dec 31, 2011$56.23M+13.0%
FY2010Dec 31, 2010$49.77M+22.4%
FY2009Dec 31, 2009$40.66M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$62.44M+14.4%
Q2 FY2026Jun 30, 2026$59.22M+15.1%
Q1 FY2026Mar 31, 2026$55.63M+9.0%
Q4 FY2025Dec 31, 2025$52.29M+10.2%
Q3 FY2025Sep 30, 2025$54.58M+13.7%
Q2 FY2025Jun 30, 2025$51.44M+12.3%
Q1 FY2025Mar 31, 2025$51.02M+22.4%
Q4 FY2024Dec 31, 2024$47.44M+23.8%
Q3 FY2024Sep 30, 2024$47.99M+10.0%
Q2 FY2024Jun 30, 2024$45.80M+6.9%
Q1 FY2024Mar 31, 2024$41.68M+21.1%
Q4 FY2023Dec 31, 2023$38.34M+15.1%
Q3 FY2023Sep 30, 2023$43.61M+29.7%
Q2 FY2023Jun 30, 2023$42.84M+7.3%
Q1 FY2023Mar 31, 2023$34.41M-10.2%
Q4 FY2022Dec 31, 2022$33.31M-1.5%
Q3 FY2022Sep 30, 2022$33.63M+3.4%
Q2 FY2022Jun 30, 2022$39.92M+30.5%
Q1 FY2022Mar 31, 2022$38.34M+25.4%
Q4 FY2021Dec 31, 2021$33.82M+16.9%
Q3 FY2021Sep 30, 2021$32.51M+12.0%
Q2 FY2021Jun 30, 2021$30.59M+13.7%
Q1 FY2021Mar 31, 2021$30.58M+16.4%
Q4 FY2020Dec 31, 2020$28.92M+22.3%
Q3 FY2020Sep 30, 2020$29.03M+11.5%
Q2 FY2020Jun 30, 2020$26.92M+2.0%
Q1 FY2020Mar 31, 2020$26.28M-0.8%
Q4 FY2019Dec 31, 2019$23.64M-13.2%
Q3 FY2019Sep 30, 2019$26.03M+2.0%
Q2 FY2019Jun 30, 2019$26.40M-2.6%
Q1 FY2019Mar 31, 2019$26.48M-2.8%
Q4 FY2018Dec 31, 2018$27.23M+3.5%
Q3 FY2018Sep 30, 2018$25.52M+10.7%
Q2 FY2018Jun 30, 2018$27.10M+9.1%
Q1 FY2018Mar 31, 2018$27.24M+20.0%
Q4 FY2017Dec 31, 2017$26.31M+7.0%
Q3 FY2017Sep 30, 2017$23.06M–
Q2 FY2017Jun 30, 2017$24.83M–
Q1 FY2017Mar 31, 2017$22.70M–
Q4 FY2016Dec 31, 2016$24.59M–

More Balchem figures

See a number that looks wrong?